Back to Search
Start Over
Supplementary Table 1. from A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Individual pharmacokinetic parameters in 3 subpopulations (no prior 14.18 mAb, prior dinutuximab mAb, prior hu14.18K322A mAb).
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....8d6536010dca5a082d1a3ab6094a3eba
- Full Text :
- https://doi.org/10.1158/1078-0432.22468166.v1